共 252 条
[1]
Di Ciaula A(2019)Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention Expert Rev Gastroenterol Hepatol 13 157-71
[2]
Wang DQ(2017)Sex and ethnic/racial-specific risk factors for gallbladder disease BMC Gastroenterol 17 153-87
[3]
Portincasa P(2012)Epidemiology of gallbladder disease: cholelithiasis and cancer Gut Liver 6 172-97
[4]
Figueiredo JC(2019)Cholelithiasis: presentation and management J Midwifery Women Health 64 289-58
[5]
Haiman C(2014)Gallstones BMJ 348 g2669-108
[6]
Porcel J(2020)The treatment of gallstone disease Deutsches Arzteblatt Int 117 148-803
[7]
Buxbaum J(1989)Structure of apolipoprotein B-100 of human low density lipoproteins Arteriosclerosis (Dallas Tex) 9 96-8
[8]
Stram D(2005)Polymorphism in APOB associated with increased low-density lipoprotein levels in both genders in the general population J Clin Endocrinol Metab 90 5797-44
[9]
Tambe N(2000)Apolipoprotein B-100 gene Xba I polymorphism and cholesterol gallstone disease Clin Genet 57 304-31
[10]
Cozen W(2018)Timing during translation matters: synonymous mutations in human pathologies influence protein folding and function Biochem Soc Transact 46 937-35